| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 10 | 2022 | 1549 | 1.690 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 3 | 2023 | 88 | 1.600 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 3 | 2018 | 66 | 1.490 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2023 | 493 | 1.440 |
Why?
|
| RNA Helicases | 2 | 2022 | 63 | 1.430 |
Why?
|
| Receptors, Androgen | 4 | 2023 | 414 | 1.270 |
Why?
|
| Inflammation | 5 | 2022 | 1446 | 1.090 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2018 | 139 | 1.030 |
Why?
|
| Neoplasms | 5 | 2023 | 2806 | 0.990 |
Why?
|
| Prostate | 6 | 2014 | 436 | 0.970 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2023 | 210 | 0.960 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2023 | 18 | 0.850 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2023 | 338 | 0.850 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2022 | 10 | 0.800 |
Why?
|
| Guanidines | 1 | 2022 | 26 | 0.800 |
Why?
|
| GATA2 Transcription Factor | 1 | 2022 | 39 | 0.800 |
Why?
|
| Keto Acids | 1 | 2022 | 56 | 0.790 |
Why?
|
| Transaminases | 1 | 2022 | 32 | 0.790 |
Why?
|
| Stromal Cells | 6 | 2014 | 302 | 0.770 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 24 | 0.750 |
Why?
|
| Co-Repressor Proteins | 1 | 2021 | 37 | 0.740 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 297 | 0.700 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2023 | 1980 | 0.680 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 358 | 0.660 |
Why?
|
| Transforming Growth Factor beta | 4 | 2014 | 467 | 0.660 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 316 | 0.630 |
Why?
|
| Gene Transfer Techniques | 2 | 2018 | 358 | 0.630 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 234 | 0.610 |
Why?
|
| Alpharetrovirus | 1 | 2018 | 5 | 0.590 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 126 | 0.560 |
Why?
|
| Cell Line, Tumor | 9 | 2023 | 3416 | 0.530 |
Why?
|
| Retroviridae | 1 | 2017 | 198 | 0.530 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2014 | 108 | 0.510 |
Why?
|
| Mice | 18 | 2022 | 17758 | 0.510 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 1728 | 0.430 |
Why?
|
| Animals | 21 | 2022 | 34392 | 0.400 |
Why?
|
| Mice, SCID | 2 | 2022 | 587 | 0.330 |
Why?
|
| Signal Transduction | 5 | 2023 | 4600 | 0.330 |
Why?
|
| Androgens | 3 | 2023 | 279 | 0.320 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 2518 | 0.310 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2017 | 634 | 0.300 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2022 | 261 | 0.290 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2007 | 56 | 0.280 |
Why?
|
| Proteins | 4 | 2014 | 1038 | 0.260 |
Why?
|
| Immediate-Early Proteins | 1 | 2005 | 58 | 0.240 |
Why?
|
| Androgen Antagonists | 2 | 2023 | 120 | 0.240 |
Why?
|
| Carcinoma | 1 | 2007 | 290 | 0.230 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 284 | 0.220 |
Why?
|
| Humans | 21 | 2023 | 125757 | 0.200 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2022 | 21 | 0.200 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 705 | 0.200 |
Why?
|
| Micrococcal Nuclease | 1 | 2001 | 7 | 0.190 |
Why?
|
| Mice, Knockout | 3 | 2021 | 3755 | 0.180 |
Why?
|
| Staphylococcus | 1 | 2001 | 69 | 0.180 |
Why?
|
| Protein Isoforms | 1 | 2022 | 404 | 0.180 |
Why?
|
| Cell Line | 4 | 2021 | 2762 | 0.180 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2021 | 140 | 0.180 |
Why?
|
| Protein Conformation | 3 | 2003 | 836 | 0.170 |
Why?
|
| Tumor Cells, Cultured | 3 | 2014 | 1077 | 0.170 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 121 | 0.170 |
Why?
|
| Th17 Cells | 1 | 2021 | 90 | 0.170 |
Why?
|
| Th1 Cells | 1 | 2021 | 153 | 0.170 |
Why?
|
| Mass Spectrometry | 1 | 2001 | 335 | 0.170 |
Why?
|
| Kupffer Cells | 1 | 2020 | 18 | 0.170 |
Why?
|
| Cell Survival | 1 | 2022 | 820 | 0.170 |
Why?
|
| Male | 15 | 2023 | 61813 | 0.170 |
Why?
|
| Mice, Nude | 5 | 2014 | 725 | 0.170 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2022 | 914 | 0.160 |
Why?
|
| Receptors, Calcitriol | 1 | 2020 | 69 | 0.160 |
Why?
|
| Hepatitis | 1 | 2020 | 57 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 4422 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 686 | 0.160 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 500 | 0.160 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 435 | 0.160 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 216 | 0.160 |
Why?
|
| Serine Endopeptidases | 2 | 2014 | 181 | 0.150 |
Why?
|
| HEK293 Cells | 1 | 2021 | 738 | 0.150 |
Why?
|
| DNA Damage | 1 | 2021 | 514 | 0.150 |
Why?
|
| DNA Repair | 1 | 2021 | 587 | 0.150 |
Why?
|
| Neovascularization, Pathologic | 4 | 2007 | 241 | 0.140 |
Why?
|
| Luciferases | 1 | 1997 | 132 | 0.140 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 4416 | 0.140 |
Why?
|
| Mitochondria | 1 | 2022 | 680 | 0.140 |
Why?
|
| Transplantation, Heterologous | 3 | 2007 | 261 | 0.140 |
Why?
|
| Calcium | 1 | 2022 | 1101 | 0.140 |
Why?
|
| Oncogenes | 1 | 2018 | 176 | 0.140 |
Why?
|
| Ribosomes | 1 | 1997 | 137 | 0.140 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2014 | 130 | 0.140 |
Why?
|
| Cysteine Endopeptidases | 1 | 2017 | 114 | 0.130 |
Why?
|
| Endopeptidases | 1 | 2017 | 116 | 0.130 |
Why?
|
| Immunotherapy | 1 | 2021 | 681 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 216 | 0.120 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2014 | 9 | 0.120 |
Why?
|
| Pteridines | 1 | 2014 | 11 | 0.120 |
Why?
|
| Phenylthiohydantoin | 1 | 2014 | 12 | 0.120 |
Why?
|
| Insulin Resistance | 1 | 2020 | 641 | 0.120 |
Why?
|
| Sequence Deletion | 1 | 2017 | 528 | 0.120 |
Why?
|
| Kallikreins | 1 | 2014 | 27 | 0.120 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 398 | 0.120 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2014 | 39 | 0.110 |
Why?
|
| Disease Progression | 2 | 2013 | 2090 | 0.110 |
Why?
|
| Myofibroblasts | 1 | 2014 | 77 | 0.110 |
Why?
|
| Benzamides | 1 | 2014 | 110 | 0.110 |
Why?
|
| Microarray Analysis | 1 | 2014 | 238 | 0.110 |
Why?
|
| Nitriles | 1 | 2014 | 146 | 0.110 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 2418 | 0.110 |
Why?
|
| beta Catenin | 1 | 2015 | 214 | 0.110 |
Why?
|
| Prostate-Specific Antigen | 1 | 2014 | 255 | 0.110 |
Why?
|
| Mice, Inbred ICR | 1 | 2013 | 149 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2014 | 420 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 511 | 0.100 |
Why?
|
| In Situ Hybridization | 1 | 2013 | 471 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2014 | 1116 | 0.100 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2015 | 376 | 0.100 |
Why?
|
| Carcinogenesis | 1 | 2015 | 340 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 1299 | 0.090 |
Why?
|
| Apoptosis | 2 | 2017 | 1818 | 0.090 |
Why?
|
| Ganglia | 1 | 2010 | 20 | 0.090 |
Why?
|
| Wound Healing | 1 | 2014 | 460 | 0.090 |
Why?
|
| Macrophages | 1 | 2014 | 627 | 0.090 |
Why?
|
| RNA, Messenger | 2 | 2014 | 2832 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2013 | 1522 | 0.080 |
Why?
|
| 3T3 Cells | 2 | 2005 | 120 | 0.080 |
Why?
|
| Female | 3 | 2022 | 67035 | 0.070 |
Why?
|
| Protein Biosynthesis | 2 | 2003 | 665 | 0.070 |
Why?
|
| Liver | 1 | 2015 | 1749 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2014 | 2374 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 141 | 0.070 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 565 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 1659 | 0.070 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2005 | 19 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2007 | 472 | 0.060 |
Why?
|
| HIV-1 | 1 | 2007 | 465 | 0.050 |
Why?
|
| Aging | 1 | 2010 | 1183 | 0.050 |
Why?
|
| Antigen-Antibody Complex | 1 | 2003 | 66 | 0.050 |
Why?
|
| Muramidase | 1 | 2003 | 94 | 0.050 |
Why?
|
| TNF Receptor-Associated Factor 4 | 1 | 2023 | 18 | 0.050 |
Why?
|
| Ubiquitination | 1 | 2023 | 168 | 0.050 |
Why?
|
| Binding Sites | 2 | 2003 | 1305 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2003 | 1084 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2001 | 62 | 0.050 |
Why?
|
| Radioimmunotherapy | 1 | 2021 | 2 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2001 | 161 | 0.050 |
Why?
|
| Protein Structure, Secondary | 1 | 2001 | 238 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 1592 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 1712 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2020 | 64 | 0.040 |
Why?
|
| Ligands | 1 | 2001 | 539 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2021 | 172 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 768 | 0.040 |
Why?
|
| Vitamin D | 1 | 2020 | 161 | 0.040 |
Why?
|
| Cell Division | 2 | 2014 | 784 | 0.040 |
Why?
|
| Coleoptera | 1 | 1997 | 14 | 0.040 |
Why?
|
| Protein Binding | 1 | 2001 | 1758 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2003 | 1033 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1997 | 319 | 0.030 |
Why?
|
| Protein Stability | 1 | 2017 | 161 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2017 | 199 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2017 | 312 | 0.030 |
Why?
|
| Cell Movement | 2 | 2014 | 860 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 1997 | 398 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 897 | 0.030 |
Why?
|
| Osteopontin | 1 | 2014 | 48 | 0.030 |
Why?
|
| Fibronectins | 1 | 2014 | 110 | 0.030 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2014 | 59 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2014 | 228 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 1410 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2014 | 139 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2014 | 347 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2015 | 163 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 264 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2014 | 357 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 670 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1997 | 1707 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1997 | 985 | 0.020 |
Why?
|
| Organoids | 1 | 2014 | 281 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 4274 | 0.020 |
Why?
|
| Time Factors | 1 | 2001 | 6355 | 0.020 |
Why?
|
| Genetic Variation | 1 | 1997 | 1506 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 746 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 682 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 658 | 0.020 |
Why?
|
| Obesity | 1 | 2020 | 2252 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1762 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 1026 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2014 | 1916 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2007 | 241 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2007 | 199 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 933 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 3110 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2021 | 12425 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 1318 | 0.010 |
Why?
|
| CHO Cells | 1 | 2003 | 169 | 0.010 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2003 | 26 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 2003 | 79 | 0.010 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2003 | 52 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 276 | 0.010 |
Why?
|
| Cricetinae | 1 | 2003 | 422 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2003 | 383 | 0.010 |
Why?
|
| Chickens | 1 | 2003 | 636 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 2003 | 173 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2003 | 357 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2003 | 241 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2002 | 152 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 3063 | 0.010 |
Why?
|
| Mutation | 1 | 2015 | 5909 | 0.010 |
Why?
|
| Antibodies | 1 | 2002 | 375 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 9119 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2002 | 781 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 3897 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 29760 | 0.010 |
Why?
|